Contact a Lawyer Now
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 27, 2019 to file lead plaintiff applications in a securities class action lawsuit against American Renal Associates Holdings, Inc. (NYSE: ARA).
American Renal and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On March 27, 2019, the Company disclosed a range of negative information including the resignation of its CFO and that its financial results for the fiscal years ended 2014 through 2017 would be restated and could no longer be relied upon due to the Company’s ongoing investigation into its revenue recognition methodology and related accounting matters.
On this news, the price of American Renal’s shares plummeted.
If you purchased securities of American Renal and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850, via email (firstname.lastname@example.org), or fill out the form on this page.
The case is Vandevar v. American Renal Associates Holdings Inc., 2:19-cv-09074. Click here to read the case complaint.